The Institute has joined hands with MagGenome Technologies to develop magnetic nanoparticles-based products including developing advanced nucleic acid extraction kits. The partnership with MagGenome Technologies will also focus on other applications of magnetic nanoparticles in the near future for providing solutions in the areas of diagnostics, therapeutics and environmental remediation.
Dr. CN Ramchand the renowned Indian Drug discovery Scientist, currently the CEO of MagGenome Technologies and Saksin Lifesciences talks about how the field of medicine will shape up in the forthcoming 100 years. The Indian actress Mamta Mohandas, sharing the dias, talks about her experiences with modern medicine and how it helped her to conquer Cancer.
MagGenome Technologies Pvt. Ltd. in association with Slovak Academy of Sciences, Kosice is organizing a conference from 10th-14th March 2020 in Slovakia. Scientists in the fields of nanotechnology and biotechnology from all across the world would convene at the Congress center, Academia, Stará.
MagGenome receives CE IVD certification for XpressDNA Isolation and Sample Collection Kits, MagGenome is primarily focused on the development of Magnetic Nanoparticles based products. The current initiatives include developing nucleic acid extraction kit using our Patented Magnetic -based technology
MagGenome Technologies Pvt. Ltd. is an India-based startup in the field of nano-biotechnology with a primary focus on developing magnetic nanoparticles-based technologies that is technically proficient and industrially viable for life science, chemical, pharmaceutical and engineering applications. With its headquarters in Cochin, India, MagGenome began operations in 2014. It was incubated in SciGenom Labs for a period of one year and is now a registered independent company from 2015. The company provides lifescience-based research solutions across the country.